期刊
EXPERIMENTAL BIOLOGY AND MEDICINE
卷 247, 期 17, 页码 1542-1547出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/15353702221106475
关键词
Sickle cell anemia; tissue factor; heme; hypercoagulability; inflammation; hemolysis
资金
- Sao Paulo Research Foundation [2014/0984-3, 2015/24666-3, 2016/14172-6]
- CNPq Brazil [309317/2016]
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001]
Hemoglobin can induce the expression and activation of tissue factor, contributing to the pathogenesis of hypercoagulability in hemolytic diseases.
Hemolytic diseases such as Sickle Cell Disease (SCD) are characterized by a natural propensity for both arterial and venous thrombosis. The ability of heme to induce tissue factor (TF) activation has been shown both in animal models of SCD, and in human endothelial cells and monocytes. Moreover, it was recently demonstrated that heme can induce coagulation activation in the whole blood of healthy volunteers in a TF-dependent fashion. Herein, we aim to further explore the cellular mechanisms by which heme induces TF-coagulation activation, using human mononuclear cells, which have been shown to be relevant to in vivo hemostasis. TF mRNA expression was evaluated by qPCR and TF procoagulant activity was evaluated using a 2-stage assay based on the generation of activated factor X (FXa). Heme was capable of inducing both TF expression and activation in a TLR4-dependent pathway. This activity was further amplified after TNF-alpha-priming. Our results provide additional details on the mechanisms by which heme is involved in the pathogenesis of hypercoagulability in hemolytic diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据